{"id":"W2292975070","doi":"10.1111/bjh.14007","title":"Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Clinical endpoint; Randomization; Lymphoma; Randomized controlled trial; Oncology; Asymptomatic; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00268684,0.0009635662,0.001200884,0.0003342394,0.0003410745,0.0007392967,0.0007928397,0.001168656,0.01159977],"category_scores_gemma":[0.001985795,0.0004135756,0.001019991,0.0004011249,0.0004048717,0.0005803229,0.0004153997,0.001876331,0.001554415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007377501,"about_ca_system_score_gemma":0.001661014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008456168,"about_ca_topic_score_gemma":0.002349757,"domain_scores_codex":[0.9989768,0.0007123678,0.00004909673,0.00007212631,0.00008777072,0.0001019056],"domain_scores_gemma":[0.9993932,0.0001378175,0.0001717446,0.00005580211,0.0000679791,0.0001732914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8990822,0.005398118,0.002196596,0.002796888,0.0009903876,0.0001360688,0.000132365,0.001135066,0.005793722,0.001307333,0.01887235,0.06215882],"study_design_scores_gemma":[0.9537879,0.02974599,0.003594583,0.0001371855,0.0002788414,0.00006523313,0.00001636763,0.0006932454,0.0004303067,0.0004988554,0.01073733,0.00001418625],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.656206,0.0180685,0.006216146,0.004195256,0.001585712,0.2501704,0.0258758,0.0008332341,0.03684889],"genre_scores_gemma":[0.6437936,0.008639723,0.01268139,0.008516137,0.0007490293,0.2660868,0.01968655,0.0001271807,0.03971957],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01159977,"threshold_uncertainty_score":0.03880513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02048215489209315,"score_gpt":0.3183431877896765,"score_spread":0.2978610328975834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}